King International Investment Limited (HKG:928) shareholders would be excited to see that the share price has had a great month, posting a 91% gain and recovering from prior weakness. Looking back a bit further, it's encouraging to see the stock is up 34% in the last year.
In spite of the firm bounce in price, you could still be forgiven for feeling indifferent about King International Investment's P/S ratio of 0.8x, since the median price-to-sales (or "P/S") ratio for the Healthcare industry in Hong Kong is also close to 0.9x. However, investors might be overlooking a clear opportunity or potential setback if there is no rational basis for the P/S.
How King International Investment Has Been Performing
King International Investment has been doing a decent job lately as it's been growing revenue at a reasonable pace. Perhaps the expectation moving forward is that the revenue growth will track in line with the wider industry for the near term, which has kept the P/S subdued. Those who are bullish on King International Investment will be hoping that this isn't the case, so that they can pick up the stock at a lower valuation.
Although there are no analyst estimates available for King International Investment, take a look at this free data-rich visualisation to see how the company stacks up on earnings, revenue and cash flow.
Is There Some Revenue Growth Forecasted For King International Investment?
The only time you'd be comfortable seeing a P/S like King International Investment's is when the company's growth is tracking the industry closely.
Retrospectively, the last year delivered a decent 4.4% gain to the company's revenues. Pleasingly, revenue has also lifted 129% in aggregate from three years ago, partly thanks to the last 12 months of growth. Therefore, it's fair to say the revenue growth recently has been superb for the company.
Comparing that recent medium-term revenue trajectory with the industry's one-year growth forecast of 13% shows it's noticeably more attractive.
With this information, we find it interesting that King International Investment is trading at a fairly similar P/S compared to the industry. Apparently some shareholders believe the recent performance is at its limits and have been accepting lower selling prices.
What Does King International Investment's P/S Mean For Investors?
Its shares have lifted substantially and now King International Investment's P/S is back within range of the industry median. Generally, our preference is to limit the use of the price-to-sales ratio to establishing what the market thinks about the overall health of a company.
We've established that King International Investment currently trades on a lower than expected P/S since its recent three-year growth is higher than the wider industry forecast. When we see strong revenue with faster-than-industry growth, we can only assume potential risks are what might be placing pressure on the P/S ratio. At least the risk of a price drop looks to be subdued if recent medium-term revenue trends continue, but investors seem to think future revenue could see some volatility.
Having said that, be aware King International Investment is showing 4 warning signs in our investment analysis, and 1 of those makes us a bit uncomfortable.
If these risks are making you reconsider your opinion on King International Investment, explore our interactive list of high quality stocks to get an idea of what else is out there.
Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
King International Investment Limited(HKG:928)股东会对股价在一个月的时间里取得的91%的涨幅感到振奋,并从之前的低迷中复苏。稍微回顾一下,令人鼓舞的是,该股去年上涨了34%。
尽管价格反弹,但你可能对King International Investment的市销率仍然感到漠不关心,因为香港医疗保健行业的中位数市销率也接近0.9倍。然而,如果市销率没有合理基础,投资者可能忽视了一个明显的机会或潜在的挫折。
King International Investment的表现如何
最近,King International Investment做得相当不错,因为其营业收入以合理的速度增长。也许前景展望是,短期内营业收入增长将与整个行业保持一致,这使市销率保持低迷。看好King International Investment的人希望不是这种情况,以便他们可以以较低的估值购买该股票。
尽管没有关于King International Investment的分析师估计数据,但请查看这个免费的数据丰富的可视化工具,了解该公司的盈利能力、营业收入和现金流情况。